Braveheart Bio, Inc. BRVE
17.88 USD -2.23 (-11.07%)
Nov 5, 2026, 11:37 AM EST
16.70 Day range 19.84
16.70 52-week range 32.00
- YTD
- -40.00%
- 1 year
- -40.00%
Held by funds
38 US ETFs and mutual funds hold BRVE · largest positions
Ownership
Held by insiders 58.16%
Held by institutions 31.06%
Float held by institutions 74.23%
Institutions 19
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Leonard Rickey Investment Advisors P.L.L.C. | 0.04% | 36,109 | 725.97K | Sep 29, 2026 |
| SBI Securities Co., Ltd. | 0.00% | 10 | 201 | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SmallCap World Fund Inc | 2.52% | 2,273,151 | 45.70M | Sep 29, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 0.87% | 779,600 | 15.67M | Aug 30, 2026 |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 0.67% | 600,000 | 12.06M | Aug 30, 2026 |
| Fidelity Select Portfolios-Select Health Care Portfolio | 0.60% | 537,444 | 10.81M | Aug 30, 2026 |
| MFS SERIES TRUST I-MFS New Discovery Fund | 0.38% | 345,984 | 6.96M | Aug 30, 2026 |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | 0.30% | 265,638 | 5.34M | Aug 30, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHIMOVITS EREZ | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Aug 6, 2026 | 0 |
| JIANGSU HENGRUI PHARMACEUTICALS CO. LTD. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Aug 6, 2026 | 7,420,090 |
| LUBNER DAVID CHARLES | Director | Purchase | Aug 6, 2026 | 55,555 |
| MURDOCH TRAVIS | Chief Executive Officer | Purchase | Aug 6, 2026 | 8,333,640 |
| RICKEY JAMES PAUL | Chief Financial Officer | Purchase | Aug 6, 2026 | 703,575 |
| VIEHBACHER CHRISTOPHER | Director | Purchase | Aug 6, 2026 | 759,857 |